medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2015, Number 07

<< Back Next >>

Ginecol Obstet Mex 2015; 83 (07)

Contraception in women with chronic diseases

Veloz-Martínez MG, Hinojosa-Cruz JC, Vital-Reyes VS, Becerra-Alcántara GI, Delgadillo-Plascencia J

Language: Spanish
References: 18
Page: 393-399
PDF size: 326.35 Kb.


ABSTRACT

Background: Almost 10% of women in reproductive age had a chronic disease, and contraception is frequently ignored by these patients. The lack of use of contraceptives methods has a higher repercussion in these patients; if pregnant, the risk is increased in morbidity and fetomaternal mortality.
Objectives: to know the contraceptive coverage in women with chronic degenerative diseases, the kind of contraceptive methods and the unsatisfied demand.
Material and methods: A descriptive study was made with the application of a survey from the one elaborated by the IMSS. It explores contraception socio-demographic data, causes of nonprotection and also explores Medical Doctor (MD) participation. Sample size was calculated in 385 women in reproductive age with a chronic disease.
Results: 428 women about 30-49 years old were interviewed, 53% of them were married, they had various diseases, the contraceptive coverage was 84%. The definitive methods were the most used with 47%, followed by the condom with 20%, intrauterine device with 13% and others in minor proportion. 38.5% of patients with sexual life have risk of pregnancy for lack of use of method or for using one of low effectiveness and continuity. Of 45 (16%) patients with sexual life that did not use methods, 29% because they wish pregnancy, 18% by collateral effects and the rest for other causes. From this same patients 21 wished getting pregnant and 24 did not, this is an unsatisfied demand of 53%. The MD´s informed about risks in case of pregnancy of 83.4% of the patients.
Conclusions: The contraceptive coverage is low and the unsatisfied demand is higher than in the general population. It requires the effective participation of health personal in this group of high reproductive risk.


REFERENCES

  1. Neinstein L. Contraception in women with special medical needs. Compr Ther 1998; 24:229-250.

  2. Gleicher N. Principles of medical care. 3a ed. Buenos Aires: Médica Panamericana, 2000; 1-13

  3. Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 2011;84(5):478-485

  4. Archivos del Consejo Nacional de Población. Indicadores de Salud Reproductiva de la República Mexicana. (Consultado en 2014, agosto 15). Disponible en http://www.conapo. gob.mx/es/CONAPO/Republica_Mexicana

  5. Organización Mundial de la Salud. Estadísticas Sanitarias mundiales 2012. (consultado en 2014, julio 27). Disponible en http://www.who.int/gho/publications/world_health_ statistics/ES_WHS2012_Full.pdf

  6. Ayoola AB, Nettleman M, Brewer J. Reasons for unprotected intercourse in adult women. J Womens Health 2007;16:302-310.

  7. Sullivan JM, Lobo RA. Considerations for contraception in women with cardiovascular disorders. Am J Obstet Gynecol 1993;168:2006-2011.

  8. ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 2006;107:1453-1472.

  9. Organización Mundial de la Salud, departamento de salud reproductiva. Medical Eligibility Criteria for Contraceptive Use. 4th ed. 2009. (Consultado en 2014, julio 27). Disponible en http://whqlibdoc.who.int/publications/ 2010/9789241563888_eng.pdf

  10. Bonnema RA, McNamara MC, Spencer AL: Contraception choices in women with underlying medical conditions. Am Fam Physician 2010;82:621-8.

  11. Laraa B, Fornet F, Goyac M, López F, De Miguel J, Molinaf M, et al. Anticoncepción, embarazo y enfermedades respiratorias minoritarias. Arch Bronconeumol 2012;48:372- 378.

  12. DeNoble AE, Hall KS, Xu X, Zochowski MK, Piehl K, Dalton VK. Receipt of prescription contraception by commercially insured women with chronic medical conditions. Obstet Gynecol 2014;123:1213-1220.

  13. Schwarz EB, Maselli J, Gonzales R. Contraceptive counseling of diabetic women of reproductive age. Obstet Gynecol 2006;107:1070-1074.

  14. WHO Statistical Information System (WHOSIS). World Health Statistics 2008. (Consultado en 2014, abril 10). Disponible en http://www.who.int/whosis/whostat/2008/ en/index.html

  15. Cross S, Bell JS, J Graham W: What you count is what you target: the implications of maternal death classification for tracking progress towards reducing maternal mortality in developing countries. Bull World Health Organ 2010;88:147-153.

  16. Velasco MV, Navarrete-HE. Mortalidad materna en el IMSS, 1991-2005.Un periodo de cambios. Rev Med Inst Mex Seguro Soc 2006;44:S121-S128.

  17. Kidwell DJ. La creciente carga que representan las enfermedades crónicas: Implicancias para la salud reproductiva. Outlook 2009; 26(1). (Consultado en 2015, mayo 12). Disponible en http://www.path.org/publications/files/ RH_outlook_26_1_sp.pdf

  18. Kittisiam T, Werawatakul Y, Nanagara R, Wantha O. Low prevalence of contraceptive counseling at Srinagarind hospital, Thailand among women of reproductive agewith systemic lupus erythematosus. Reprod Health 2013; 10:21. doi: 10.1186/1742-4755-10-21. (Consultado en 2015, mayo 12). Disponible en http://www.reproductive-health-journal. com/content/10/1/21




2020     |     www.medigraphic.com